Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2025-12-27 @ 11:49 AM
Study NCT ID:
NCT00853957
Status:
COMPLETED
Last Update Posted:
2012-04-30
First Post:
2009-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-26
First Submit QC Date:
None
Study First Post Date:
2009-03-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-06
Results First Submit QC Date:
None
Results First Post Date:
2011-01-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-04-26
Last Update Post Date:
2012-04-30
Last Update Post Date Type:
ESTIMATED